Master architects of spider world discovered in northern Australia
A team of scientists led by The University of Western Australia has discovered two new species of trapdoor spiders in the ...
The Scientist5d
Correcting the Mutation Behind a Genetic Eye Disease
Base editing corrected a mutation that causes macular degeneration, highlighting the potential of gene therapy to treat ...
Healio4d
Latest data show progress of GA therapies in the pipeline
The current state of treatment for geographic atrophy is marked by two approved therapies that slow GA progression: ...
Managed Healthcare Executive12d
FDA Approves First-Ever Cell Therapy Treatment for Rare Progressive Eye Disease
Encelto is small, semi-permeable capsule implanted in the eye that contains allogeneic retinal pigment epithelium cells ...
Healio12d
Q&A: White pupils in a photo can be a sign of a serious condition, but not always
Flash photos typically produce a red reflection in people’s eyes, but sometimes that reflection can appear white or gray, ...
Annexon: Despite Major Catalysts, Stock Is Trading Almost At Cash
Financially, Annexon has a strong cash position, providing a runway of 5-8 quarters, but the stock trades almost at cash due to market skepticism. Risks include the ex-US trial locations for GBS and ...
Yahoo Finance2d
Annexon, Inc. (ANNX)
Only Program that has Demonstrated Significant Vision Protection in Standard and Low Light Conditions and Significant Preservation of Photoreceptors in the Fovea Region Critical for Visual Acuity ...
pharmaphorum1d
NICE backs first ophthalmic bevacizumab for NHS use
Cost-effectiveness watchdog NICE has recommended Lytenava as an option for wet AMD in adults who have signs of recent disease progression, no permanent structural damage to the central fovea ...